EGFR activation by EGFR mutation (such as exon-19 deletions, L858R or T790M mutation) could induce PD-L1 (programmed cell death-ligand 1) expression in advanced NSCLC [10]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.